FdaApplication

NDA 212477

Back to search

Identifiers

Properties

PropertyValue
applicant_nameGILEAD SCIENCES INC
application_typeNDA
approval_date2019-08-28

Products (2)

ProductActive ingredientStrengthDosage form
HARVONILEDIPASVIR; SOFOSBUVIR45MG/PACKET;200MG/PACKETPELLETS;ORAL
HARVONILEDIPASVIR; SOFOSBUVIR33.75MG/PACKET;150MG/PACKETPELLETS;ORAL

2 products